BioSpace News Archive

Feb. 20, 2020 13:00 UTC scPharmaceuticals Inc. to Present at the 9 th Annual SVB Leerink Global Healthcare Conference BURLINGTON, Mass.--( BUSINESS WIRE )-- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer, will present at the

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 100,000 shares of Geron common stock as inducements to two newly-hired employees in connection with commencement of employment with the Company.

After, Inc., the global leader in Warranty Analytics Solutions since 2005, announced today that it will be a major participant and sponsor at the Field Service Medical Conference in San Diego, California on February 24-26, 2020.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the year ended December 31, 2019, on Thursday, February 27, 2020, before the U.S. financial markets open.

Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the fourth quarter and full year ended December 31, 2019.

FORMA Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation and Rare Pediatric Disease designation for its lead clinical asset, FT-4202, in development as a disease-modifying treatment for sickle cell disease (SCD

RAZ Mobility, a provider of mobile assistive technology, announced the launch of the RAZ Memory Cell Phone.

Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it will report financial results for the fourth quarter and full year 2019 as well as provide a corporate update at 4:30 p.m. EST on February 27, 2020.

Rigel Pharmaceuticals, Inc. announced that it will report its fourth quarter and year end 2019 financial results after market close on Thursday, February 27, 2020.

Feb. 20, 2020 13:00 UTC Study reports on the first human cellular and metabolomics-based test for the evaluation of drugs for cardiotoxic effects MADISON, Wis.--( BUSINESS WIRE )-- Stemina Biomarker Discovery, Inc., today announced study results showing the high performance of the company’s Cardio quick Predict test in identifying cardiotoxic effects for a large number of well-characterized drugs. These results suggest the drug screening test could provide drug developers